CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study-Reference-Cited by-同舟云学术

CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study

Published:2023-08-21 Issue:11 Volume:58 Page:1223-1228
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Wang Jiasheng^ORCID,Alkrekshi Akram,Dasari Srilatha,Lin Hsin-Ti Cindy^ORCID,Elantably Dina,Armashi Abdul Rahman Al

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-02086-1.pdf

Reference17 articles.

1. Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med. 2022;28:2124–32.

2. Rosetti F, Madera-Salcedo IK, Rodriguez-Rodriguez N, Crispin JC. Regulation of activated T cell survival in rheumatic autoimmune diseases. Nat Rev Rheumatol. 2022;18:232–44.

3. Looney RJ. Treating human autoimmune disease by depleting B cells. Ann Rheum Dis. 2002;61:863–6.

4. Jhaveri KS, Schlam I, Holtzman NG, Peravali M, Richardson PK, Dahiya S, et al. Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy. Blood Adv. 2020;4:6019–22.

5. Hanly JG, Thompson K, Skedgel C. The use of administrative health care databases to identify patients with rheumatoid arthritis. Open Access Rheumatol. 2015;7:69–75.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Myositis-Associated Interstitial Lung Disease;Journal of Clinical Medicine;2024-07-11

2. Pharmacotherapy of autoimmune rheumatic diseases – from monoclonal antibodies to CAR T cells: 20 years later;Rheumatology Science and Practice;2024-06-26

3. CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases;Cureus;2024-05-23

4. Chimeric antigen receptors: “CARs” in the fast lane for rheumatology;Current Opinion in Rheumatology;2024-03-26

5. Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0;Current Opinion in Rheumatology;2023-12-15